Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002007919-24-000045
Filing Date
2024-09-10
Accepted
2024-09-10 17:00:58
Documents
1
Period of Report
2024-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1726002051.html 4  
1 FORM 4 wk-form4_1726002051.xml 4 9913
  Complete submission text file 0002007919-24-000045.txt   11473
Mailing Address 11622 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Lappe Mark (Reporting) CIK: 0001366074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241290710

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)